Cargando…
A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report
Bullous pemphigoid is an acquired autoimmune subepidermal blistering disease that can arise following exposure to systemic medication, referred to as drug-induced bullous pemphigoid. Drug-induced bullous pemphigoid is a rare but potentially serious immune-related adverse event that should be conside...
Autores principales: | Gresham, Louise M, Kirchhof, Mark G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034281/ https://www.ncbi.nlm.nih.gov/pubmed/36968984 http://dx.doi.org/10.1177/2050313X231160926 |
Ejemplares similares
-
Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
por: Nash, David, et al.
Publicado: (2022) -
Imiquimod-induced bullous pemphigoid: A case report
por: Li, Heidi Oi-Yee, et al.
Publicado: (2023) -
Annular bullous pemphigoid: A case report and review of literature
por: Arès, Steffie, et al.
Publicado: (2022) -
A case of radiotherapy-induced bullous pemphigoid with unusually delayed onset: A case report
por: El Barch, Maha, et al.
Publicado: (2023) -
Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
por: Lansang, Rafael Paolo, et al.
Publicado: (2023)